5.16. Analysis.

Comparison 5 Rivastigmine 5 cm2 patch (4.6 mg/day) versus placebo, Outcome 16 at least one adverse event of nausea by 24 weeks.

Comparison 5 Rivastigmine 5 cm2 patch (4.6 mg/day) versus placebo, Outcome 16 at least one adverse event of nausea by 24 weeks.